(Q41726692)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9515185%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

review article

1 reference

title

Clinical pharmacokinetics of fibric acid derivatives (fibrates) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9515185%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9515185%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

D B Miller

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9515185%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 February 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9515185%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

number of pages

8

1 reference

Clinical Pharmacokinetics

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9515185%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9515185%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9515185%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

155-162

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9515185%20AND%20SRC:MED&resulttype=core&format=json

Interactions with hydroxymethylglutaryl-coenzyme A reductase inhibitors

10 November 2019

cites work

1 reference

12 December 2020

Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses

1 reference

12 December 2020

Drug interactions with grapefruit: whose responsibility is it to warn the public?

1 reference

12 December 2020

Bezafibrate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hyperlipidaemia

1 reference

12 December 2020

Pharmacokinetics of drugs in patients with the nephrotic syndrome

1 reference

12 December 2020

Erythromycin-felodipine interaction

1 reference

12 December 2020

Nonhormonal drugs and cancer

1 reference

12 December 2020

Interaction of citrus juices with felodipine and nifedipine

1 reference

12 December 2020

Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia

1 reference

12 December 2020

Echolucent carotid artery plaques are associated with elevated levels of fasting and postprandial triglyceride-rich lipoproteins.

1 reference

12 December 2020

Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study

1 reference

12 December 2020

Grapefruit juice-terfenadine single-dose interaction: magnitude, mechanism, and relevance

1 reference

12 December 2020

Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjects

1 reference

12 December 2020

Severe gastrointestinal bleeding induced by a probable hydroxycoumarin-bezafibrate interaction

1 reference

12 December 2020

Gemfibrozil interaction with warfarin sodium (coumadin)

1 reference

12 December 2020

Pharmacokinetics of bezafibrate after single and multiple doses in the presence of renal failure

1 reference

12 December 2020

Effect of a single high-fat meal on endothelial function in healthy subjects

1 reference

12 December 2020

Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.

1 reference

12 December 2020

Fibrates and statins in the treatment of hyperlipidaemia: an appraisal of their efficacy and safety

1 reference

12 December 2020

Comparative effects of gemfibrozil and clofibrate in type III hyperlipoproteinemia

1 reference

12 December 2020

A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators

1 reference

12 December 2020

Triglyceride-rich lipoproteins and atherosclerosis, from fast to feast

1 reference

12 December 2020

The fibrates in clinical practice: focus on micronised fenofibrate

1 reference

12 December 2020

In vitro binding study of gemfibrozil to human serum proteins and erythrocytes: interactions with other drugs.

1 reference

12 December 2020

Gemfibrozil: interaction with glyburide

1 reference

12 December 2020

[Comparison of the pharmacokinetics of a quick-release bezafibrate formulation with a sustained-release formulation. 1. Single-dose administration]

1 reference

12 December 2020

Effect of hemodialysis on plasma kinetics of fenofibrate in chronic renal failure

1 reference

12 December 2020

Mechanism of action of gemfibrozil on lipoprotein metabolism

1 reference

12 December 2020

Gemfibrozil therapy in primary hypertriglyceridemia associated with coronary heart disease. Effects on metabolism of low-density lipoproteins

1 reference

12 December 2020

Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia

1 reference

12 December 2020

Disposition pharmacokinetics of bezafibrate in man

1 reference

12 December 2020

Plasma triglyceride and coronary heart disease

1 reference

12 December 2020

Grapefruit juice and drugs. How significant is the interaction?

1 reference

12 December 2020

Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia

1 reference

12 December 2020

Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation

1 reference

12 December 2020

Absorption and disposition of 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid, WIN 35,833, in rats, monkeys, and men

1 reference

12 December 2020

Micronised fenofibrate

1 reference

12 December 2020

Pharmacodynamic activity of lipoprotein lipase and hepatic lipase, and pharmacokinetic parameters measured in normolipidaemic subjects receiving ciprofibrate (100 or 200 mg/day) or micronised fenofibrate (200 mg/day) therapy for 23 days.

1 reference

12 December 2020

[Comparison of the pharmacokinetics of a quick-release bezafibrate formulation with a sustained-release formulation. 2. Multiple-dose administration and chronopharmacokinetics]

1 reference

12 December 2020

Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy

1 reference

12 December 2020

Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid

1 reference

12 December 2020

Biotransformation of pravastatin sodium (I). Mechanisms of enzymic transformation and epimerization of an allylic hydroxy group of pravastatin sodium

1 reference

12 December 2020

Effect of clofibrate on postheparin plasma triglyceride lipase activities in patients with hypertriglyceridemia

1 reference

12 December 2020

Influence of Gemfibrozil and Clofibrate on Metabolism of Cholesterol and Plasma Triglycerides in Man

1 reference

12 December 2020

Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients

1 reference

12 December 2020

Delayed clearance of postprandial chylomicrons and their remnants in the hypoalphalipoproteinemia and mild hypertriglyceridemia syndrome

1 reference

12 December 2020

Pharmacokinetics of the combination of fluvastatin and gemfibrozil

1 reference

12 December 2020

Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole

1 reference

12 December 2020

Interactions of warfarin with drugs and food

1 reference

12 December 2020

Modification of metabolism and distribution of lipids by ethyl chlorophenoxyisobutyrate

1 reference

12 December 2020

Ketoconazole to reduce the need for cyclosporine after cardiac transplantation

1 reference

12 December 2020

Clinical pharmacokinetic study of procetofene, a new hypolipidemic drug, in volunteers

1 reference

12 December 2020

The influence of renal insufficiency and haemodialysis on the kinetics of ciprofibrate

1 reference

12 December 2020

Erythromycin-felodipine interaction: Magnitude, mechanism, and comparison with grapefruit juice*

1 reference

12 December 2020

In vivo inhibition profile of cytochrome P450TB (CYP2C9) by (±)-fluvastatin*

1 reference

12 December 2020

Effect of short-term clofibrate on glucose metabolism and insulin secretion in patients with mild maturity-onset diabetes mellitus

1 reference

12 December 2020

10.2165/00003088-199834020-00003

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9515185%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

10 November 2019

1002314365

0 references

Fatcat ID

release_dbgg2srhbrgvlgj2r5zg2t3uxa

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dbgg2srhbrgvlgj2r5zg2t3uxa

24 November 2022

mapped directly with Wikidata item

1 reference